Drake & Associates’s UnitedHealth UNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-1,420
Closed -$443K 114
2025
Q2
$443K Buy
1,420
+310
+28% +$118K 0.11% 76
2025
Q1
$581K Buy
1,110
+204
+23% +$104K 0.16% 52
2024
Q4
$477K Hold
906
0.14% 61
2024
Q3
$530K Buy
906
+233
+35% +$132K 0.17% 49
2024
Q2
$343K Buy
673
+8
+1% +$3.92K 0.12% 55
2024
Q1
$329K Buy
665
+16
+2% +$8.13K 0.12% 56
2023
Q4
$342K Buy
+649
New +$346K 0.14% 56
2023
Q1
Sell
-1,349
Closed -$715K 76
2022
Q4
$715K Buy
1,349
+131
+11% +$69.4K 0.38% 21
2022
Q3
$615K Buy
1,218
+508
+72% +$267K 0.35% 20
2022
Q2
$365K Buy
+710
New +$357K 0.21% 30

Other funds holding UNH

Drake & Associates's UNH Position: Q3 2025 in Review

Drake & Associates sold out of UnitedHealth (UNH) in Q3 2025, closing a stake of 1,420 shares — an estimated $443K sold.

Drake & Associates first reported a position in UNH in Q2 2022 and held it in 10 quarters. The position peaked at $715K in Q4 2022. 3,159 funds tracked by Wall St. Rank hold UNH as of Q3 2025.

  • Drake & Associates reported no remaining UnitedHealth position as of Q3 2025 after selling out during the quarter.
  • Drake & Associates sold 1,420 UnitedHealth shares in Q3 2025, an estimated $443K.
  • Drake & Associates first reported a position in UnitedHealth in Q2 2022 and held it in 10 quarters.
  • Drake & Associates's UnitedHealth position peaked at $715K in Q4 2022.
  • 3,159 funds tracked by Wall St. Rank held UnitedHealth as of Q3 2025.

Based on Drake & Associates's 13F filing for Q3 2025, filed 6 Nov 2025.